Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Helicopter Emergency Medical Service (HEMS) in Northern Ireland: An Analysis of the First 100 Cases.

Boylan E, McLaughlin R, O'Rorke G, Thorpe R, Monaghan D.

Ulster Med J. 2019 May;88(2):98-101. Epub 2019 Apr 27.

2.

Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.

Irvine MW, Fang G, Sapkota K, Burnell ES, Volianskis A, Costa BM, Culley G, Collingridge GL, Monaghan DT, Jane DE.

Eur J Med Chem. 2019 Feb 15;164:471-498. doi: 10.1016/j.ejmech.2018.12.054. Epub 2018 Dec 28. Review.

PMID:
30622023
3.

The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.

Sapkota K, Dore K, Tang K, Irvine M, Fang G, Burnell ES, Malinow R, Jane DE, Monaghan DT.

Biochem Pharmacol. 2019 Jan;159:140-153. doi: 10.1016/j.bcp.2018.11.018. Epub 2018 Nov 29.

PMID:
30503374
4.

Using Sprint Velocity Decrement to Enhance Acute Sprint Performance.

Cochrane DJ, Monaghan D.

J Strength Cond Res. 2018 Jun 20. doi: 10.1519/JSC.0000000000002707. [Epub ahead of print]

PMID:
29927891
5.

Developing an Interactive Data Visualization Tool to Assess the Impact of Decision Support on Clinical Operations.

Huber TC, Krishnaraj A, Monaghan D, Gaskin CM.

J Digit Imaging. 2018 Oct;31(5):640-645. doi: 10.1007/s10278-018-0065-z.

PMID:
29777325
6.

In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.

Alsaad HA, DeKorver NW, Mao Z, Dravid SM, Arikkath J, Monaghan DT.

Neurochem Res. 2019 Jan;44(1):61-77. doi: 10.1007/s11064-018-2526-7. Epub 2018 Apr 12.

PMID:
29651654
7.

Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

Burnell ES, Irvine M, Fang G, Sapkota K, Jane DE, Monaghan DT.

J Med Chem. 2019 Jan 10;62(1):3-23. doi: 10.1021/acs.jmedchem.7b01640. Epub 2018 Mar 5.

PMID:
29446949
8.

A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors.

Chopra DA, Sapkota K, Irvine MW, Fang G, Jane DE, Monaghan DT, Dravid SM.

Sci Rep. 2017 Jul 31;7(1):6933. doi: 10.1038/s41598-017-07292-8.

9.

Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.

Sapkota K, Irvine MW, Fang G, Burnell ES, Bannister N, Volianskis A, Culley GR, Dravid SM, Collingridge GL, Jane DE, Monaghan DT.

Neuropharmacology. 2017 Oct;125:64-79. doi: 10.1016/j.neuropharm.2017.07.007. Epub 2017 Jul 11.

10.

Investigating laparoscopic psychomotor skills in veterinarians and veterinary technicians.

Kilkenny J, Santarossa A, Mrotz V, Walker M, Monaghan D, Singh A.

Vet Surg. 2017 Apr;46(3):433-440. doi: 10.1111/vsu.12626. Epub 2017 Feb 3.

PMID:
28158937
11.

The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function.

Gupta SC, Ravikrishnan A, Liu J, Mao Z, Pavuluri R, Hillman BG, Gandhi PJ, Stairs DJ, Li M, Ugale RR, Monaghan DT, Dravid SM.

Sci Rep. 2016 Dec 6;6:38321. doi: 10.1038/srep38321.

12.

Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus.

France G, Fernández-Fernández D, Burnell ES, Irvine MW, Monaghan DT, Jane DE, Bortolotto ZA, Collingridge GL, Volianskis A.

Neuropharmacology. 2017 Jan;112(Pt A):76-83. doi: 10.1016/j.neuropharm.2016.08.010. Epub 2016 Aug 12.

13.

Lectin Affinity Chromatography (LAC).

O'Connor BF, Monaghan D, Cawley J.

Methods Mol Biol. 2017;1485:411-420.

PMID:
27730567
14.

GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.

Sapkota K, Mao Z, Synowicki P, Lieber D, Liu M, Ikezu T, Gautam V, Monaghan DT.

J Pharmacol Exp Ther. 2016 Mar;356(3):702-11. doi: 10.1124/jpet.115.230391. Epub 2015 Dec 16.

15.

Synthesis of a Series of Novel 3,9-Disubstituted Phenanthrenes as Analogues of Known NMDA Receptor Allosteric Modulators.

Irvine MW, Fang G, Eaves R, Mayo-Martin MB, Burnell ES, Costa BM, Culley GR, Volianskis A, Collingridge GL, Monaghan DT, Jane DE.

Synthesis (Stuttg). 2015 Jun 1;47(11):1593-1610. doi: 10.1055/s-0034-1380114.

16.

Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu.

Chopra DA, Monaghan DT, Dravid SM.

Mol Pharmacol. 2015 Oct;88(4):650-9. doi: 10.1124/mol.115.100396. Epub 2015 Jul 10.

17.

Income inequality and educational assortative mating: Evidence from the Luxembourg Income Study.

Monaghan D.

Soc Sci Res. 2015 Jul;52:253-69. doi: 10.1016/j.ssresearch.2015.02.001. Epub 2015 Feb 11.

PMID:
26004461
18.

The Convergence of Virtual Reality and Social Networks: Threats to Privacy and Autonomy.

O'Brolcháin F, Jacquemard T, Monaghan D, O'Connor N, Novitzky P, Gordijn B.

Sci Eng Ethics. 2016 Feb;22(1):1-29. doi: 10.1007/s11948-014-9621-1. Epub 2015 Jan 1.

PMID:
25552240
19.

Mesenchymal stem cells and a vitamin D receptor agonist additively suppress T helper 17 cells and the related inflammatory response in the kidney.

Duffy MM, McNicholas BA, Monaghan DA, Hanley SA, McMahon JM, Pindjakova J, Alagesan S, Fearnhead HO, Griffin MD.

Am J Physiol Renal Physiol. 2014 Dec 15;307(12):F1412-26. doi: 10.1152/ajprenal.00024.2014. Epub 2014 Oct 22.

20.

Parenteral poppy seed tea packs a powerful punch.

Monaghan D, Peckler B.

N Z Med J. 2013 Dec 13;126(1387):175-8.

PMID:
24362742
21.

Inhibition of protein synthesis and JNK activation are not required for cell death induced by anisomycin and anisomycin analogues.

Monaghan D, O'Connell E, Cruickshank FL, O'Sullivan B, Giles FJ, Hulme AN, Fearnhead HO.

Biochem Biophys Res Commun. 2014 Jan 10;443(2):761-7. doi: 10.1016/j.bbrc.2013.12.041. Epub 2013 Dec 12.

PMID:
24333448
22.

Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D.

Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT.

Neuropharmacology. 2013 Nov;74:96-107. doi: 10.1016/j.neuropharm.2013.04.035. Epub 2013 Apr 29.

23.

Classification of sporting activities using smartphone accelerometers.

Mitchell E, Monaghan D, O'Connor NE.

Sensors (Basel). 2013 Apr 19;13(4):5317-37. doi: 10.3390/s130405317.

24.

Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro.

Volianskis A, Bannister N, Collett VJ, Irvine MW, Monaghan DT, Fitzjohn SM, Jensen MS, Jane DE, Collingridge GL.

J Physiol. 2013 Feb 15;591(4):955-72. doi: 10.1113/jphysiol.2012.247296. Epub 2012 Dec 10.

25.

The NMDA receptor as a target for cognitive enhancement.

Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G, Irvine MW, Costa BM, Monaghan DT, Bortolotto ZA, Molnár E, Lodge D, Jane DE.

Neuropharmacology. 2013 Jan;64:13-26. doi: 10.1016/j.neuropharm.2012.06.051. Epub 2012 Jul 11. Review.

26.

Cutaneous Rhodotorula treated with photodynamic therapy.

Means AD, Sisto K, Lichon V, Monaghan D, O'Keefe P, Tung R.

Dermatol Surg. 2012 Jul;38(7 Pt 1):1100-3. doi: 10.1111/j.1524-4725.2012.02373.x. Epub 2012 Mar 8. No abstract available.

PMID:
22404186
27.

Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Monaghan DT, Irvine MW, Costa BM, Fang G, Jane DE.

Neurochem Int. 2012 Sep;61(4):581-92. doi: 10.1016/j.neuint.2012.01.004. Epub 2012 Jan 17. Review.

28.

Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors.

Irvine MW, Costa BM, Volianskis A, Fang G, Ceolin L, Collingridge GL, Monaghan DT, Jane DE.

Neurochem Int. 2012 Sep;61(4):593-600. doi: 10.1016/j.neuint.2011.12.020. Epub 2012 Jan 13.

29.

Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.

Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Laube B, Jane DE, Monaghan DT.

Neuropharmacology. 2012 Mar;62(4):1730-6. doi: 10.1016/j.neuropharm.2011.11.019. Epub 2011 Dec 6.

30.

Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.

Irvine MW, Costa BM, Dlaboga D, Culley GR, Hulse R, Scholefield CL, Atlason P, Fang G, Eaves R, Morley R, Mayo-Martin MB, Amici M, Bortolotto ZA, Donaldson L, Collingridge GL, Molnár E, Monaghan DT, Jane DE.

J Med Chem. 2012 Jan 12;55(1):327-41. doi: 10.1021/jm201230z. Epub 2011 Dec 14.

31.

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo.

Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C.

Mol Neurodegener. 2011 Oct 5;6:68. doi: 10.1186/1750-1326-6-68.

32.

Creating an open mind.

Monaghan D.

Australas Psychiatry. 2011 Jul;19 Suppl 1:S73-5. doi: 10.3109/10398562.2011.583052.

PMID:
21878025
33.

Pharmacology of NMDA Receptors.

Monaghan DT, Jane DE.

In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 12.

34.

A novel family of negative and positive allosteric modulators of NMDA receptors.

Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Skifter DA, Jane DE, Monaghan DT.

J Pharmacol Exp Ther. 2010 Dec;335(3):614-21. doi: 10.1124/jpet.110.174144. Epub 2010 Sep 21.

35.

Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.

Suárez F, Zhao Q, Monaghan DT, Jane DE, Jones S, Gibb AJ.

Eur J Neurosci. 2010 Aug;32(3):359-67. doi: 10.1111/j.1460-9568.2010.07298.x. Epub 2010 Jul 6.

36.

Twin removal in digital holography using diffuse illumination.

Monaghan DS, Kelly DP, Pandey N, Hennelly BM.

Opt Lett. 2009 Dec 1;34(23):3610-2. doi: 10.1364/OL.34.003610.

PMID:
19953136
37.

Regulation of mu opioid receptor internalization by the scaffold protein RanBPM.

Talbot JN, Skifter DA, Bianchi E, Monaghan DT, Toews ML, Murrin LC.

Neurosci Lett. 2009 Dec 11;466(3):154-8. doi: 10.1016/j.neulet.2009.09.048. Epub 2009 Sep 27.

38.

Statistical investigation of the double random phase encoding technique.

Monaghan DS, Gopinathan U, Situ G, Naughton TJ, Sheridan JT.

J Opt Soc Am A Opt Image Sci Vis. 2009 Sep;26(9):2033-42.

PMID:
19721689
39.

N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse.

Costa BM, Feng B, Tsintsadze TS, Morley RM, Irvine MW, Tsintsadze V, Lozovaya NA, Jane DE, Monaghan DT.

J Pharmacol Exp Ther. 2009 Nov;331(2):618-26. doi: 10.1124/jpet.109.156752. Epub 2009 Aug 14.

40.

Idiopathic intracranial hypertension in men.

Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, Preechawat P, Corbett JJ, Newman NJ, Biousse V.

Neurology. 2009 Jan 27;72(4):304-9. doi: 10.1212/01.wnl.0000333254.84120.f5. Epub 2008 Oct 15.

41.

Role of phase key in the double random phase encoding technique: an error analysis.

Monaghan DS, Situ G, Gopinathan U, Naughton TJ, Sheridan JT.

Appl Opt. 2008 Jul 20;47(21):3808-16.

PMID:
18641750
42.

Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons.

Whitney NP, Peng H, Erdmann NB, Tian C, Monaghan DT, Zheng JC.

FASEB J. 2008 Aug;22(8):2888-900. doi: 10.1096/fj.07-104661. Epub 2008 Apr 10.

43.

NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones.

Brothwell SL, Barber JL, Monaghan DT, Jane DE, Gibb AJ, Jones S.

J Physiol. 2008 Feb 1;586(3):739-50. Epub 2007 Nov 22.

44.

Key-space analysis of double random phase encryption technique.

Monaghan DS, Gopinathan U, Naughton TJ, Sheridan JT.

Appl Opt. 2007 Sep 10;46(26):6641-7.

PMID:
17846658
45.

Cryptanalysis of optical security systems with significant output images.

Situ G, Gopinathan U, Monaghan DS, Sheridan JT.

Appl Opt. 2007 Aug 1;46(22):5257-62.

PMID:
17676139
46.

Determinants of radiologists' productivity in private group practices in California.

Monaghan DA, Kassak KM, Ghomrawi HM.

J Am Coll Radiol. 2006 Feb;3(2):108-14.

PMID:
17412020
47.

Regional variations in NMDA receptor downregulation in streptozotocin-diabetic rat brain.

Bean L, Zheng H, Patel KP, Monaghan DT.

Brain Res. 2006 Oct 18;1115(1):217-22. Epub 2006 Aug 30.

PMID:
16938282
48.
49.

A known-plaintext heuristic attack on the Fourier plane encryption algorithm.

Gopinathan U, Monaghan DS, Naughton TJ, Sheridan JT.

Opt Express. 2006 Apr 17;14(8):3181-6.

PMID:
19516459
50.

Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil.

Maurice T, Meunier J, Feng B, Ieni J, Monaghan DT.

J Pharmacol Exp Ther. 2006 May;317(2):606-14. Epub 2006 Jan 5.

PMID:
16397090

Supplemental Content

Loading ...
Support Center